home / stock / atrc / atrc news


ATRC News and Press, AtriCure Inc. From 01/16/26

Stock Information

Company Name: AtriCure Inc.
Stock Symbol: ATRC
Market: NASDAQ
Website: atricure.com

Menu

Get ATRC Alerts

News, Short Squeeze, Breakout and More Instantly...

ATRC - AI Diagnostics: The End of the High-Cost Imaging Era

VANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) --   Equity-Insider.com News Commentary – The AI medical imaging market is entering a phase of explosive 25.8% annual growth through 2034 [1] . This systemic re-rating is driven by healthcare’s structural pivot fr...

ATRC - AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-14 16:16:06 ET AtriCure, Inc. (ATRC) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 1:30 PM EST... Read the full article on Seeking Alpha For further details see: AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

ATRC - AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced preliminary financial results for the fourth quarter and full year 2025 and prov...

ATRC - Alphatec is the top performing healthcare equipment stock YTD

2025-12-22 12:12:50 ET More on healthcare stocks My S&P 500 Prediction On Sector Outperformers And Laggards In 2026 IHI: A Passive ETF For Medical Device Exposure XLV: The Simple Case For Overweighting U.S. Health Care Top 10 healthcare stocks according t...

ATRC - AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming J.P. Morgan 44 th ...

ATRC - AtriCure Announces the First Patients Treated with Novel Dual Energy Platform

New technology combines Pulsed Field Ablation (PFA) and Advanced Radiofrequency Ablation with AtriCure’s EnCompass ® clamp to reduce treatment time for surgical ablation patients AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments an...

ATRC - AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Piper Sandler 37 th ...

ATRC - AtriCure, Inc. (ATRC) Presents at UBS Global Healthcare Conference 2025 Transcript

2025-11-10 16:41:33 ET AtriCure, Inc. (ATRC) UBS Global Healthcare Conference 2025 November 10, 2025 2:00 PM EST... Read the full article on Seeking Alpha For further details see: AtriCure, Inc. (ATRC) Presents at UBS Global Healthcare Conference 2025 Transcript

ATRC - AtriCure raises 2025 revenue outlook to $532M-$534M as product launches propel double-digit growth

2025-10-29 23:17:17 ET More on AtriCure AtriCure, Inc. (ATRC) Q3 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on AtriCure Historical earnings data for AtriCure Financial information for AtriCure Read the full article on Seeking ...

ATRC - AtriCure, Inc. (ATRC) Q3 2025 Earnings Call Transcript

2025-10-29 23:16:23 ET AtriCure, Inc. (ATRC) Q3 2025 Earnings Call October 29, 2025 4:30 PM EDT Company Participants Michael H. Carrel - CEO, President & Director Angela Wirick - Chief Financial Officer ... Read the full article on Seeking Alpha For f...

Previous 10 Next 10